alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CDC’s Strategy to Reinforce Confidence in COVID-19 Vaccines

Engage 

Communities 

& Individuals 

Objective: Engage communities in a sustainable, equitable and inclusive way—using two-way communication to listen, build trust, 

and increase collaboration.

✓

✓

✓

Empower vaccine recipients to share their personal stories and reasons for vaccination within their circles of influence.

Work with health departments and national partners to engage communities around vaccine confidence and service delivery strategies, 

including adaptation of vaccination sites to meet community needs.

Collaborate with trusted messengers—such as faith-based and community leaders—to tailor and share culturally relevant messages and 

materials with diverse communities.

Empower 

Healthcare 

Personnel

Objective: Promote confidence among healthcare personnel* in their decision to get vaccinated and to recommend vaccination to

their patients.

✓

✓

✓

Engage national professional associations, health systems, and healthcare personnel often and early to ensure a clear understanding of 

the vaccine development and approval process, new vaccine technologies, and the benefits of vaccination.

Ensure healthcare systems and medical practices are equipped to create a culture that builds confidence in COVID-19 vaccination.

Strengthen the capacity of healthcare professionals to have empathetic vaccine conversations, address myths and common questions, 

provide tailored vaccine information to patients, and use motivational interviewing techniques when needed.

Build Trust

Objective: Share clear, complete, and accurate messages about COVID-19 vaccines and take visible actions to build trust in the vaccine, 

the vaccinator, and the system in coordination with federal, state, and local agencies and partners. 

✓

✓

✓

Communicate transparently about the process for authorizing, approving, making recommendations for, monitoring the safety of,

distributing, and administering COVID-19 vaccines, including data handling.

Provide regular updates on benefits, safety, side effects and effectiveness; clearly communicate what is not known.

Proactively address and mitigate the spread and harm of misinformation via social media platforms, partners, and trusted messengers.

*Personnel = All staff working in healthcare settings, including physicians, PAs/NPs, nurses, allied health professionals, pharmacists, social workers, support staff, and community health workers
Exhibit 32.3



Written Statement of the Chief Operating Officer

Pursuant to 18 U.S.C. §1350



Solely for the purposes of complying with 18 U.S.C. §1350, I, the undersigned President and Chief Operating Officer of Regency Centers Corporation, the general partner of Regency Centers, L.P.(the
Partnership), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Partnership for the quarter ended September 30, 2005 (the Report) fully complies with the requirements of
Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.



Date: November 7, 2005



|                                                                                    
|------------------------------------------------------------------------------------
|/s/ Mary Lou Fiala                                                                  
|Mary Lou Fiala                                                                      
|Chief Operating Officer of Regency Centers Corporation,general partner of registrant
No. 10-10860.

#### Martha Silvia Barba de Garza, Petitioner v. United States.

565 U.S. 853, 132 S. Ct. 181,

181 L. Ed. 2d 91,

2011 U.S. LEXIS 5988.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 415 Fed. Appx. 560.
95

Section C: Recommended Funding Levels, by State

Kentucky

Program Intervention Budgets: 2014

8,900 $56.4 million

Deaths in State Caused by Smoking

Annual average smoking-attributable deaths 8,900

Youth aged 0-17 projected to die from smoking 118,900

Annual Costs Incurred in State from Smoking

Total medical $1,927 million

State Revenue from Tobacco Sales and Settlement

FY 2012 tobacco tax revenue $282.9 million

FY 2012 tobacco settlement payment $101.8 million

Total state revenue from tobacco sales and settlement $384.7 million

Percent Tobacco Revenue to Fund at Recommended Level 15%

Annual Total (Millions) Annual Per Capita

Minimum Recommended Minimum Recommended

I. State and Community Interventions 

Multiple social resources working together will 

have the greatest long-term population impact.

$15.2 $19.0 $3.47 $4.34

II. Mass-Reach Health Communication Interventions 

Media interventions work to prevent smoking initiation, 

promote cessation, and shape social norms.

$2.4 $3.5 $0.55 $0.80

III. Cessation Interventions 

Tobacco use treatment is effective and highly cost-effective. $16.5 $26.5 $3.77 $6.05

IV. Surveillance and Evaluation 

Publicly funded programs should be accountable and 

demonstrate effectiveness.

$3.4 $4.9 $0.78 $1.12

V. Infrastructure, Administration, and Management 

Complex, integrated programs require experienced 

staff to provide fiscal management, accountability, 

and coordination.

$1.7 $2.5 $0.39 $0.56

TOTAL $39.2 $56.4 $8.96 $12.87

Note: A justification for each program element and the rationale for the budget estimates are provided in Section A. The funding estimates presented are based on adjustments for changes in population and cost-of-living increases since Best Practices—2007 was published. The actual 

funding required for implementing programs will vary depending on state characteristics, such as prevalence of tobacco use, sociodemographic 

factors, and other factors. See Appendix E for data sources on deaths, costs, revenue, and state-specific factors. 

Centers for Disease Control and Prevention • Office on Smoking and Health

www.cdc.gov/tobacco • tobaccoinfo@cdc.gov • 1 (800) CDC-INFO or 1 (800) 232-4636 

2014
# C_2013352EN.01002102.xml

| 30.11.2013 | EN | Official Journal of the European Union | C 352/21 |
| --- | --- | --- | --- |

30.11.2013

EN

Official Journal of the European Union

C 352/21

---

Action brought on 20 September 2013 — Euromed v OHIM — DC Druck-Chemie (EUROSIL)

(Case T-524/13)

2013/C 352/40

Language in which the application was lodged: English

Parties

Parties

Applicant: Euromed, SA (Mollet del Vallès, Spain) (represented by: E. Sugrañes Coca, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: DC Druck-Chemie GmbH (Ammerbuch-Altingen, Germany)

Other party to the proceedings before the Board of Appeal:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 27 June 2013 given in Case R 1829/2012-1; and |
| --- | --- |

—

Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 27 June 2013 given in Case R 1829/2012-1; and

| — | Order the defendant to pay the costs of proceedings. |
| --- | --- |

—

Order the defendant to pay the costs of proceedings.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: The other party to the proceedings before the Board of Appeal

Applicant for a Community trade mark:

Community trade mark concerned: The word mark ‘EUROSIL’ for certain goods in Class 1 — Community trade mark application No 8 540 049

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: The applicant

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: The word mark ‘EUROSIL-85’ for goods in Class 5 — Community registration No 6 140 099 and the word mark ‘EUROSIL-85’ for goods in Class 5 — Spanish registration No 2 785 209

Mark or sign cited in opposition:

Decision of the Opposition Division: Rejected the opposition in its entirety

Decision of the Opposition Division:

Decision of the Board of Appeal: Dismissed the appeal

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8 (1)(b) CTMR.

Pleas in law:

---
AIR TRANSPORT INTERNATIONAL 

U.S. Department of Transportation 

Docket Operations, M-30 

West Building, ground floor 

Room W12-140 

1200 New Jersey Avenue SE 

Washington, DC 20590. 

RE: Exemption 9890/Docket FAA-2009-0416 

October 24th, 2012 

T 

00. 

Zfl!Z ;.~;u ·:;•., D 1: ·L1 q u ' . i ·- ~ j ! { lJ 

Air Transport International Limited Liability Company hereby requests a two (2) year extension to 

Exemption 9890 from 14 C.F.R. § 121.310 (d)(4)on the same basis as original arid subsequent issuance. 

The Exemption allows A TI to carry passengers without a cockpit control device for each emergency exit 

light, subject to the conditions and limits o(the Exemp~iol}.. : ... ·:·.~~-- :.).: . . : .. :L .. :~-:._ ... '1·· .. ~-- , .::k~-·--~~.-~-- ... , r ~" 

~-- .. ,•. \_ ... _ •· -·· ....... ". !.-;! -:-~-:_·- •· -·r::\~: : ... ~. :_._ ..... ~.t-~.?·-.::::··:· _·\ , ..... ~--

The original and. sul)sequent bases fot' isstiani::e' ofthe Exemption remain unchanged: . . , 

1. The current three-position cockpit switch design provides added safety by reducing the likelihood 

of unintended emergency battery discharge. 

2., Turning the number 1 emergency electrical control switch to its "off" position activates the 

. emergency lighting. Two flight deck personnel have access to this switching operation. 

3: .. _Opening, the emergency light control circuit breaker also activates the emergency lighting . 

. .. Althoughthe use: of a circuit breaker as an electrical switch contradicts FAA policy, it does 

prov,ide a back1,1p-that is readily accessible to at least one flight deck crewmember. 

4. The pes series ,aircraft has a well-established flight crew emergency training syllabus. Any 

qhang~~ to a cockpit functional aspect affecting emergency procedures could introduce a higher 

risk dtiring a period requiring quick reaction than the original regulation change sought to reduce. 

5. Since the DC8 series aircraft began operations on September 8, 1959, its approximately 50 year 

operations record has not identified any problems regarding the existing installed emergency light 

system. 

:.' . 

Thank you for your consideration. 

,t;;IGregory-K:,;r;~~~~.\~ -~:.",>: :; , ·: ·· : .· 

Director of S~fe_t)', Secur;ity., ~ . . :.: .. 

& Regul~t_ory ~ompMance ,., 

greg.troxell@airtr~nsport.cc 

Office-501-615-3500 -e:x;t.1504 

Cell-407-405-6910 . ·. - , I >' 

Fax-50 1-603-2059 . J . 

····:. .· 

:.' 

,. 

.. . '·' 

'"i 

·-·r 

..... ,_: / ~t~.n ·_; 

·.-.... 

. , . -~. ·. ,-

!. -

,., .. , '.• ·t- . 

·one cantr~ll center'~ 2S't)cft~n·fr~'l1 Road .'Littie R.ock, Arkansas 12202 usA 

Phone: 501-615-3500 • www.airtransport.cc : . . •. : • : ': t •,, ~ : ,J ; :. 't _; ; : ~ ·' . .. ' ' . ; i_'' -~ . . . . 

I ''.
52

DLA Distribution Hill, Utah

Mr. Preston Kriegshauser

Deputy Director

Preston Kriegshauser became the deputy director of DLA Distribution Hill, 

Utah, in December 2015. Kriegshauser has over 30 years of experience in 

distribution, contract oversight and manufacturing operations.

Kriegshauser previously served as the contracting offi cer representative since 

his arrival at DLA Distribution Hill, Utah, in February 2010. 

Before joining DLA, he was a contractor charged with training Continuing 

Government Activities on all aspects of post-competition accountability 

throughout the DLA Distribution network. Kriegshauser was responsible 

for ensuring that all Continuing Government Activities were fully aware and 

completely capable of executing all phases of post-competition accountability 

to include surveillance activities and documentation. 

For more than 20 years, Kriegshauser worked in manufacturing and distribution operations with the Wilkerson 

Corporation in Englewood, Colo. He also served at Wal-Mart Distribution in Loveland, Colo., and Pottsville, Pa., 

where he was chosen to be a key player for the start-up of a hi-velocity mechanized grocery distribution center in 

northeast Pennsylvania. During his time at the Wilkerson Corporation, he became a certifi ed internal auditor for 

ISO 9000 and 9001, and trained others to become certifi ed.

Kriegshauser received an honorable discharge from the United States Navy in 1981, aft er proudly serving as a fl ight 

deck director aboard the USS Saratoga.
I 

116TH CONGRESS 

1ST SESSION H. R. 3152 

To designate the facility of the United States Postal Service located at 

456 North Meridian Street in Indianapolis, Indiana, as the ‘‘Richard 

G. Lugar Post Office’’. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 6, 2019 

Mr. CARSON of Indiana (for himself, Mr. BAIRD, Mr. BANKS, Mrs. BROOKS

of Indiana, Mr. BUCSHON, Mr. HOLLINGSWORTH, Mr. PENCE, Mr. VISCLOSKY, and Mrs. WALORSKI) introduced the following bill; which was referred to the Committee on Oversight and Reform 

A BILL 

To designate the facility of the United States Postal Service 

located at 456 North Meridian Street in Indianapolis, 

Indiana, as the ‘‘Richard G. Lugar Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. RICHARD G. LUGAR POST OFFICE. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 456 North Meridian Street in 

6 Indianapolis, Indiana, shall be known and designated as 

7 the ‘‘Richard G. Lugar Post Office’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 3152 IH

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘Richard G. Lugar 

5 Post Office’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
No. 10-11042.

#### Anthony McNeal, Petitioner v. Illinois.

565 U.S. 864, 132 S. Ct. 206,

181 L. Ed. 2d 110,

2011 U.S. LEXIS 6494.

October 3, 2011.

Petition for writ of certiorari to the Appellate Court of Illinois, First District, denied.

*111Same case below, 405 Ill. App. 3d 647, 352 Ill. Dec. 856, 955 N.E.2d 32.
*DoD 4000.25-7-M, March 2004*

DLM 4000.25, Volume 4

**DIC FDR/FDS FORMAT**

**REPLY TO REQUEST FOR SUMMARY LEVEL ADJUSTMENT ANDRESPONSE TO FOLLOW-UP ON REQUEST FOR SUMMARY LEVEL BILLING ADJUSTMENT**

112

	APPENDIX 3.10

1
No. 11-5226.

#### Carl Snyder, Petitioner v. Joseph T. Smith, Superintendent, Shawangunk Correctional Facility.

565 U.S. 935, 132 S. Ct. 384,

181 L. Ed. 2d 242,

2011 U.S. LEXIS 6362.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.

Justice Sotomayor took no part in the consideration or decision of this petition.
[Federal Register Volume 63, Number 140 (Wednesday, July 22, 1998)]
[Notices]
[Page 39284]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19449]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket No. GT98-83-000]


Northwest Pipeline Corporation; Notice of Proposed Changes in 
FERC Gas Tariff and Filing of Non-Conforming Service Agreements

July 16, 1998.
    Take notice that on July 13, 1998, Northwest Pipeline Corporation 
(Northwest) tendered for filing and acceptance several non-conforming 
service agreements and, as part of its FERC Gas Tariff, Third Revised 
Volume No. 1, the following tariff sheets to become effective August 
13, 1998:

Fifth Revised Sheet No. 363
Second Revised Sheet No. 364
Original Sheet No. 365
Sheets Nos. 366 through 374

    Northwest states that each of the service agreements contains a 
contract-specific operational flow order provision and/or a provision 
imposing subordinate primary corridor rights with an exemption from 
reservation charge adjustments for nominations that are not scheduled 
as a result of the subordinate scheduling priority. The tariff sheets 
are submitted to add these agreements to the list of non-conforming 
service agreements contained in Northwest's tariff, and to remove three 
terminated service agreements from such list.
    Any person desiring to be heard or to protest this filing should 
file a motion to intervene or a protest with the Federal Energy 
Regulatory Commission, 888 First Street, N.E., Washington, D.C. 20426, 
in accordance with Sections 385.214 and 385.211 of the Commission's 
Rules and Regulations. All such motions or protests must be filed as 
provided in Section 154.210 of the Commission's Regulations. Protests 
will be considered by the Commission in determining the appropriate 
action to be taken, but will not serve to make protestants parties to 
the proceedings. Any person wishing to become a party must file a 
motion to intervene. Copies of this filing are on file with the 
Commission and are available for public inspection in the Public 
Reference Room.
David P. Boergers,
Acting Secretary.
[FR Doc. 98-19449 Filed 7-21-98; 8:45 am]
BILLING CODE 6717-01-M
Exhibit 10.23
 Amendment to the  Ferro Corporation Supplemental Defined Contribution Plan for Executive Employees
  Background
 A.
    
    The Plan currently provides that a Participants account be deemed to be invested in Ferro
Common Stock and/or cash.B.
    
    The Company desires to change, effective January 1, 2010, the deemed cash investment to an
investment that mirrors the stable asset investment under the Ferro Corporation Savings and
Stock Ownership Plan.C.
    
    Section 9.1 of Part A of the Plan and Section 9.1 of Part B of the Plan permit the Company to
amend the Plan, provided that the amendment does not adversely affect the rights of
Participants, and no Participant has yet earned the right to any contribution for the Plan
Year beginning January 1, 2010; however, the prior provisions notwithstanding, the Plan may be
amended to reduce or eliminate the future deemed interest or earnings credited to the amounts
held in participants accounts.
 Amendment
   5.2
    
    Form of Distribution. Distribution will be in the form of a single
lump sum payment. The portion of the Participants Account deemed to be invested in
the Ferro Common Stock Account under Section 6.4 will be distributed in the form of
Ferro Common Stock unless the Participant elects to receive payment of that portion in
cash. The portion of the Participants Account deemed to be invested in the Stable
Asset Account under Section 6.4 will be distributed in the form of cash.




---



##### 



Method for Crediting Investment Return
 Post-2000 Contributions
 Pre-2001 Contributions
 Post-2009 Investments
 Periodic Adjustment of Accounts
 2




---



##### 



Investment Election Changes
    3.
    
    It is the intent of the Company that the foregoing amendments do not constitute a material
modification to Part A of the Plan such to subject deferred compensation that was earned and
vested under the Plan as of December 31, 2004 to the requirements of Code Section 409A.4.
    
    Capitalized terms not otherwise defined herein have the same meanings ascribed to them in the
Plan. 3




---



##### 



th
 Ferro CorporationBy:
    /s/ James F. KirschJames F. KirschChairman, President & Chief
 Executive Officer 4
No. 10-11281.

#### Adonis Berle Whitby, Petitioner v. Office of Personnel Management.

565 U.S. 811, 132 S. Ct. 87,

181 L. Ed. 2d 18,

2011 U.S. LEXIS 6944.

October 3, 2011.

Motion of petitioner for leave to proceed in forma pauperis denied. Petitioner is allowed until October 24, 2011, within which to pay the docketing fee required by Rule 38(a) and to submit a petition in compliance with Rule 33.1 of the Rules of this Court.
The 2As & R 

ASK about tobacco use: 

“Do you currently smoke or use other forms of tobacco?” 

ADVISE the patient to quit: 

“Quitting tobacco is one of the best things you can do 

for your health. I strongly encourage you to quit. Are 

you interested in quitting?” 

REFER the patient to resources: 

IF READY TO QUIT: Provide direct referrals to 

resources that will assist the patient in quitting. Provid

direct referrals. Prescribe medications, if appropriate. 

“This is a resource I recommend. It will provide you 

with support, help you create a plan to quit, and talk t

you about how to overcome urges you might have to 

smoke after you quit.” 

IF NOT READY TO QUIT: Strongly encourage patien

to consider quitting by using personalized motivationa

messages. Let them know you are there to help them 

when they are ready. 

Recommended resources include: 

•	Free telephone-based state tobacco quitlines:

1-800-QUIT-NOW 

•	The National Cancer Institute’s website:

www.Smokefree.gov 

•	The National Cancer Institute’s text-messaging quit

smoking program: SmokefreeTXT;

Text QUIT to 47848 

• The Department of Health and Human Services webs

BeTobaccoFree.gov 

•	Appropriate community-based or local cessation

resources (e.g., classes, support groups) 
	 	 	 	 	

	 	

	 	

	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	

The 5As 

ASK about tobacco use: 

“Do you currently smoke or use other forms of 

tobacco?” 

ADVISE the patient to quit: 

“Quitting tobacco is one of the best things you can do 

for your health. I strongly encourage you to quit. Are 

you interested in quitting?” 

ASSESS readiness to quit: 

“Are you interested in quitting tobacco?”

ASSIST the patient in quitting: 

IF READY TO QUIT: Provide brief counseling and 

medication (if appropriate). Refer patients to other 

support resources that can complement your care 

(e.g., quitlines, Smokefree.gov, SmokefreeTXT,

BeTobaccoFree.gov, group counseling).

For tips on how to offer brief counseling, see:

www.ahrq.gov/path/tobacco.htm. 

IF NOT READY TO QUIT: Strongly encourage patien

to consider quitting by using personalized motivationa

messages. Let them know you are there to help them 

when they are ready. 

ARRANGE for follow up: 

Follow up regularly with patients who are trying to qui